This information was published on 2026-03-16T00:12:19 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2605381 (IR 1887070) |
| (220) |
15 Oct 2025
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment of obstructive sleep apnea, symptomatic snoring, and sleep disorders. |
| (540) | OXNIMBI |
| (550) | Word |
| (730) |
Apnimed, Inc.
|
Find out more about publications on the About page.